- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05011136
Physician Reimbursement Home Patients
Physician Reimbursement for Home Dialysis: Assessment of Validity of CMS Compensation for Nephrologists
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Physician reimbursement today for care of a home dialysis patient is a capitated reimbursement, defined by the age of the patient and their days on home dialysis. Due to the multiple advantages of home therapy, CMS is working on increasing home dialysis uptake; however, there is little to no data on the time and effort involved in providing care to home dialysis patients.
In this study, we will develop and distribute a survey to capture the components of home dialysis patient care and the perceived time and effort of nephrologists across the US to do so. This will provide data for CMS as they consider the adjustment of their policy values in physician reimbursement for home dialysis patient care, which is currently labeled as misvalued (Centers for Medicare and Medicaid Services, 2021).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
San Jose, California, United States, 95128
- Satellite Health Care
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All nephrologists in the US who care for dialysis patients.
Exclusion Criteria:
- Nephrologists who have not cared for dialysis patients in the last year.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To provide data to facilitate a data-driven adjustment of the capitated physician payment for caring for home dialysis patients.
Time Frame: Day 1
|
Compilation of survey data from US nephrologists with dialysis patients.
|
Day 1
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SIH 129
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ESRD
-
Everett MeyerNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting
-
Azienda Ospedaliera, Ospedale Civile di LegnanoAO Garbagnate-BollateUnknown
-
Northwell HealthCompleted
-
Peking Union Medical College HospitalBeijing Anzhen Hospital; First Hospital of China Medical University; The Luhe... and other collaboratorsRecruiting
-
Satellite HealthcareCompleted
-
University of Alabama at BirminghamBaxter Healthcare CorporationCompleted
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruiting
Clinical Trials on No intervention. This is a qualitative study
-
King's College LondonCompleted
-
Satellite HealthcareCompleted
-
QuantalX NeuroscienceCompletedHealthy | Hemorrhage | Cognitive Impairment | Dementia | Fibromyalgia | TBI (Traumatic Brain Injury) | Cognitive Decline | Concussion, Brain | MS (Multiple Sclerosis) | Adhd | CVA | ABD | MciIsrael
-
Boston IVFCompleted
-
Nicoline LøkkenCompleted
-
University of Colorado, DenverNational Institute on Drug Abuse (NIDA)CompletedThe Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural ConnectivityDrug Use | Neurodevelopmental Abnormality | Cannabis Use Disorder | PREG1 | Fetal Exposure During PregnancyUnited States
-
The Hong Kong Polytechnic UniversityRecruiting
-
The Hong Kong Polytechnic UniversityHealth and Medical Research FundCompletedPediatric Cancer | SurvivorshipHong Kong
-
Kardium Inc.St. Paul's Hospital, CanadaCompletedAtrial FibrillationCanada